SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-19-001495
Filing Date
2019-01-29
Accepted
2019-01-29 16:30:53
Documents
1
Group Members
CENTRESTONE VENTURES INC.DR. ALBERT D. FRIESEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G centre20190125_sc13g.htm SC 13G 91984
  Complete submission text file 0001437749-19-001495.txt   93656
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90788 | Film No.: 19549037
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4-1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address 4-1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-928-7900
CentreStone Ventures Limited Partnership (Filed by) CIK: 0001765980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A2 | Fiscal Year End: 1231
Type: SC 13G